Graft transection and warm perfusion in situ in canine partial orthotopic liver transplantation.
Liver transplantation is now proven therapy for various forms of end-stage liver disease in children; however, the problem of donor liver shortage remains. To investigate the feasibility of graft procurement from living, genetically related adult donors without injury to either donor or recipient, partial orthotopic liver transplantation (PLT) using a graft transected and warm perfused in situ was evaluated in beagles; the viability of the graft was assessed in terms of energy metabolism, including blood ketone body ratio (KBR), as well as of recipient survival. PLT was performed in two groups with venovenous bypass. The left half of the donor liver was transected in situ, flush perfused with 2 l lactated Ringer's solution (4 degrees C in group A, 20 degrees C in group B), and immediately implanted into the recipient, who was totally hepatectomized, care having been taken to leave the inferior vena cava intact. Four of seven dogs survived for 5 days or longer (longest, 8 days) in group A and six of eight dogs (longest, 20 days) in group B. Causes of death were gastrointestinal bleeding, intussusception, or infection but not graft dysfunction. In both groups the KBR decreased significantly during the anhepatic period, recovered rapidly to the pre-anhepatic level after revascularization, and was maintained within a normal range thereafter. No significant differences in the time course of changes in KBR were seen between the two groups.(ABSTRACT TRUNCATED AT 250 WORDS)
Tanaka
K
K
Second Department of Surgery, Faculty of Medicine, Kyoto University, Japan.
Tokunaga
Y
Y
Zaima
M
M
Sakai
Y
Y
Yamamoto
Y
Y
Ueda
J
J
Takada
Y
Y
Yamaguti
M
M
Katayama
T
T
Kitakado
Y
Y
D000818:Animals; D004285:Dogs; D004734:Energy Metabolism; D006085:Graft Survival; D007657:Ketone Bodies / Q000097:blood; D007773:Lactates / Q000097:blood; D019344:Lactic Acid; D008099:Liver / Q000098:blood supply / Q000378:metabolism; D016031:Liver Transplantation; D008722:Methods; D010477:Perfusion; D011773:Pyruvates / Q000097:blood; D019289:Pyruvic Acid; D013696:Temperature
D007657:Ketone Bodies; D007773:Lactates; D011773:Pyruvates; D019344:Lactic Acid; D019289:Pyruvic Acid